Skip to main content
Premium Trial:

Request an Annual Quote

Duke Bioinformaticists to Adapt SPSS Business Software For Biology

NEW YORK, July 9-Duke University's bioinformatics project has signed an agreement with the business software company SPSS to adapt its data mining software system for life sciences use, the company said today.

 

Through the agreement, the Duke Bioinformatics Shared Resource will have user licenses, training and technical support for Clementine, SPSS's statistics and data mining software.

 

Duke bioinformaticists will adapt the software, which was designed for business applications like cross-selling, forecasting and survey research, for use in analyzing microarray, combinatorial chemistry and clinical data. The Duke developers will share their work with SPSS.

 

An SPSS representative said in a statement that the software will probably be easy to adapt to bioinformatics due to its simple user interface and its ability to manage large amounts of data.

 

SPSS, based in Chicago, is a multinational software company.

 

The Duke Bioinformatics Shared Resource is operated by Duke's cancer center.

 

For further details about the agreement, see the press release.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more